What is it about?
In this article we discuss the impact of microbiota on metabolic, physiological and immunological pathways involving autoimmune, gut and liver related diseases. We also discuss the application of fecal microbiome transplantation (FMT) for the treatment of multiple chronic gut associated inflammatory diseases such as Clostridium difficile infection (CDI) and inflammatory bowel disease (IBD). The potential role of human migration across continents and cultures leading to alteration in their microbiome and its implication in health and disease is also discussed.
Featured Image
Why is it important?
In this article we discuss the impact of microbiota on metabolic, physiological and immunological pathways involving autoimmune and gut and liver related diseases.
Perspectives
Read the Original
This page is a summary of: Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases, Inflammation & Allergy - Drug Targets, April 2016, Bentham Science Publishers,
DOI: 10.2174/1871528114666160128150747.
You can read the full text:
Contributors
The following have contributed to this page